Stocks  /  NASDAQ  /  Klotho Neurosciences Inc.

Klotho Neurosciences Inc.

Industry:   Health Care – Biotechnology: Biological Products (No Diagnostic Substances)

Stock Symbol:   KLTONASDAQ

 

Animal Usage:   Animal Testing

Our Opinion

Klotho Neurosciences Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company confirms in corporate disclosures that it utilizes animal subjects for product testing.

“Animal studies supported by the Company over the past two years in mouse and non-human primate models of rapid aging, in models of human Alzheimer’s disease, and in models of ALS have shown that over-expression and amplification of the tissue levels of s-KL using a gene therapy approach result in highly favorable therapeutic outcomes in every model tested.” Read the article for more details

Company Description

Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer’s disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig’s disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.

Company Website: https://www.klothoneuro.com

Contact:  IR@klothoneuro.com
Scroll to Top